GT Biopharma Inc (NAS:GTBP)
$ 2.96 0.02 (0.68%) Market Cap: 6.34 Mil Enterprise Value: -3.63 Mil PE Ratio: 0 PB Ratio: 0.76 GF Score: 33/100

GT Biopharma Inc Extraordinary Shareholders Meeting Transcript

Oct 10, 2022 / 06:00PM GMT
Release Date Price: $54 (-1.64%)
Unidentified Participant

Good morning, and welcome to the special meeting of stockholders of GT Biopharma, Inc. Please note that this event is being webcast.

I would now like to turn the conference over to Michael Breen, Executive Chairman of the Board and Interim Chief Executive Officer. Mr. Breen, please go ahead, sir.

Michael Breen
GT Biopharma, Inc. - Executive Chairman of the Board & Interim Chief Executive Officer

Thank you, and good morning or afternoon depending on your location. I am Michael Breen, Executive Chairman of the Board and Interim Chief Executive Officer of GT Biopharma. Joining me today is Mr. Manu Ohri, our Chief Financial Officer.

On behalf of our Board of Directors and Management Team, I would like to welcome you to this special meeting of GT Biopharma stockholders. I will act as Chair for the meeting, and I now call the meeting to order.

We are hosting a virtual meeting of stockholders with those of you attending [doing so] exclusively via our web portal and by telephone. We believe that through this online

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot